A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis.
about
Tacrolimus (FK506) for induction of remission in refractory ulcerative colitisOral pathology in inflammatory bowel diseaseAdvances in refractory ulcerative colitis treatment: A new therapeutic target, Annexin A2Role of surgery in severe ulcerative colitis in the era of medical rescue therapyGlucose intolerance and diabetes mellitus in ulcerative colitis: pathogenetic and therapeutic implicationsOptimization of the treatment with immunosuppressants and biologics in inflammatory bowel diseaseTacrolimus for the Treatment of Ulcerative ColitisTacrolimus or infliximab for severe ulcerative colitis: short-term and long-term data from a retrospective observational studyRapid Induction Therapy with Oral Tacrolimus in Elderly Patients with Refractory Ulcerative Colitis Can Easily Lead to Elevated Tacrolimus Concentrations in Blood: A Report of 5 CasesCurrent approaches to the management of new-onset ulcerative colitis.Hepatic complications induced by immunosuppressants and biologics in inflammatory bowel disease.PharmGKB summary: cyclosporine and tacrolimus pathwaysEuropean evidence-based Consensus on the management of ulcerative colitis: Current management.Development of ulcerative colitis in a patient with multiple sclerosis following treatment with interferon beta 1a.Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis.Toxic megacolon.Ulcerative colitis: current treatment strategies and future prospects.Infliximab: the evidence for its place in therapy in ulcerative colitis.Management of acute severe ulcerative colitis.Review article: acute severe ulcerative colitis - evidence-based consensus statements.Looking for predictive factors of clinical response to adsorptive granulocyte and monocyte apheresis in patients with ulcerative colitis: markers of response to GMA.A complicated case of tacrolimus-induced rapid remission after cesarean section in the early third trimester for refractory severe ulcerative colitis flaring in the initial period of gestation.Effects of oral tacrolimus as a rapid induction therapy in ulcerative colitisCurrent treatment of ulcerative colitisImmunomodulators and immunosuppressants for Japanese patients with ulcerative colitisThe earliest trough concentration predicts the dose of tacrolimus required for remission induction therapy in ulcerative colitis patientsComputer-Aided Prediction of Long-Term Prognosis of Patients with Ulcerative Colitis after Cytoapheresis Therapy.Mucosal healing in inflammatory bowel disease-a true paradigm of success?Tacrolimus--finally!Systematic Review and Meta-analysis: Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis.Infliximab versus Cyclosporine Treatment for Severe Corticosteroid-Refractory Ulcerative Colitis: A Korean, Retrospective, Single Center Study.Qing-dai powder promotes recovery of colitis by inhibiting inflammatory responses of colonic macrophages in dextran sulfate sodium-treated micePrognostic factors for colectomy in refractory ulcerative colitis treated with calcineurin inhibitorsEFFICACY OF TACROLIMUS FOR INDUCTION OF REMISSION IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS.Medium-term results of oral tacrolimus treatment in refractory inflammatory bowel disease.Colon Mucosa Exhibits Loss of Ectopic MUC5AC Expression in Patients with Ulcerative Colitis Treated with Oral Tacrolimus.Adverse events associated with the use of cyclosporine in patients with inflammatory bowel disease.Treatment of inflammatory bowel disease: a review of medical therapy.The effect of liver transplantation for primary sclerosing cholangitis on disease activity in patients with inflammatory bowel diseasePrognostic factors affecting early colectomy in patients with moderate to severe ulcerative colitis treated with calcineurin inhibitors.
P2860
Q24242681-478A239F-C62C-4A4D-A35C-6D6624BEEA59Q26739055-11F8FA3B-6041-48AE-9E38-7394962AA190Q26798299-E1166CDC-E2EE-46D4-8CEF-26234B5CC21AQ26830235-6C508205-9D0E-4088-A9C8-E27C30223A0CQ26866110-35266E90-F509-4AB7-B144-97E4658FA4CCQ26866940-6A8C5073-F680-4851-9404-3A518CB57BE0Q26997361-49F7C2CB-1CA7-4A3A-9A99-CA4064B66049Q31004717-FEB67FC1-F66B-4380-90F9-106AF455DDBDQ33596231-DF3BC645-252E-4C67-B711-02863B7F3239Q33633288-2179A13D-4FFA-43CE-B905-6D9B4F286D64Q33654733-A5B6FE60-FF36-4185-B9E5-085142259265Q33989902-1FB91AB2-D6AE-4D4B-90FB-F6DB6D3ADD3DQ34025054-EDA02481-BF34-4226-A2CC-028F448C8566Q34098754-163B62E3-F2E4-4855-9D39-7122164459C2Q34213109-4B46068B-9CC8-4FB9-B042-C59000B75CCEQ34225376-DFAC6D9C-AFAC-4ED9-A2FA-38FD685A1AE6Q34408967-535D4EA8-F208-42F1-9235-34AC8EEC20A6Q34449876-DDB84E13-8B27-440C-AD79-2DC71CE49F67Q34508900-8ECE8424-B74E-441A-BA28-B9572D03D2BAQ34528270-F863E3CA-9E27-4C4F-95FF-B7FC4A1ECE82Q34582547-D4DAA712-7793-4F6E-B9FE-FDE7F3421CFDQ34939334-08EA4BB5-C7E6-4308-A448-A5846B5467ECQ35069498-9DA6B085-B613-4E7A-A1B3-A17724007A95Q35171533-B5B0770D-C96F-4CC3-B4D3-8DA3151769DFQ35200481-FA213FF3-E8D3-46B7-992D-FFCA611352E4Q35618156-11ADC183-CE48-4197-90A0-9CE95F2C7B7DQ35674635-1C7D9EDF-6706-4A30-9E16-0F6D5D6FD06BQ35749943-0ED5FBFC-60E1-46D9-82F2-30F11D84F5E1Q35768958-3E497A4F-307D-45A1-A424-ACFFA1AC2268Q35889006-B2798716-3235-42FB-87DD-270205A3E288Q36037115-7EDCD2D8-894E-49AF-97E4-4FBA5B391C1FQ36157372-194E0C95-ABE5-4563-B8E7-6FA747D7AB28Q36285603-F295FAAD-93BC-4570-BE35-87617A7CD356Q36317757-B7878586-7908-46A0-8AD2-D68BF4212D94Q36700682-BAFE6B8C-55C8-4B3D-B39A-729AFBA10F40Q36830507-6F5AE2C2-A673-45EF-B140-AA15112FB35BQ37051414-C103F99A-6111-4F3B-8AB6-8278E6825028Q37058862-2E705C48-7A77-486E-A1CA-B9B2655EE564Q37078616-9891F099-3420-4E94-9D76-5E7792CCC353Q37106707-31C71CD4-CA7C-4EB5-901B-BAD663012FE0
P2860
A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
A randomised dose finding stud ...... refractory ulcerative colitis.
@ast
A randomised dose finding stud ...... refractory ulcerative colitis.
@en
type
label
A randomised dose finding stud ...... refractory ulcerative colitis.
@ast
A randomised dose finding stud ...... refractory ulcerative colitis.
@en
prefLabel
A randomised dose finding stud ...... refractory ulcerative colitis.
@ast
A randomised dose finding stud ...... refractory ulcerative colitis.
@en
P2093
P2860
P356
P1433
P1476
A randomised dose finding stud ...... refractory ulcerative colitis.
@en
P2093
M Nakamura
P2860
P304
P356
10.1136/GUT.2005.081794
P407
P577
2006-02-16T00:00:00Z